Cargando…
Genome Editing for Cystic Fibrosis
Cystic fibrosis (CF) is a monogenic recessive genetic disorder caused by mutations in the CF Transmembrane-conductance Regulator gene (CFTR). Remarkable progress in basic research has led to the discovery of highly effective CFTR modulators. Now ~90% of CF patients are treatable. However, these modu...
Autor principal: | Wang, Guoshun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297084/ https://www.ncbi.nlm.nih.gov/pubmed/37371025 http://dx.doi.org/10.3390/cells12121555 |
Ejemplares similares
-
Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing
por: Maule, Giulia, et al.
Publicado: (2020) -
Editorial: Genome Editing to Treat Cystic Fibrosis and Other Pulmonary Diseases
por: Vaidyanathan, S., et al.
Publicado: (2022) -
Delivering on the promise of gene editing for cystic fibrosis
por: Hodges, Craig A., et al.
Publicado: (2018) -
On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis
por: Ensinck, Marjolein, et al.
Publicado: (2021) -
Gene and Base Editing as a Therapeutic Option for Cystic Fibrosis—Learning from Other Diseases
por: Mention, Karen, et al.
Publicado: (2019)